|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.01.26 - 12:18
|
New energy, AI, EV and biotech to drive Hong Kong IPO growth: HKEX (SCMP)
|
|
|
New energy, artificial intelligence, electric vehicle (EV) and biotechnology companies will remain the driving force behind Hong Kong's initial public offering (IPO) market in the coming years, according to the head of bourse operator Hong Kong Exchanges and Clearing (HKEX).
“In the past year, dozens of new companies in green energy, automation and other sectors have listed in Hong Kong, enabling them to scale their research and global impact,” wrote Bonnie Chan Yiting, CEO of HKEX, in an......
|
|
|
20.01.26 - 09:42
|
HRV Pharma, Haleos Labs partner to develop, manufacture orphan and niche APIs (Times of India)
|
|
|
HRV Pharma and Haleos Labs have joined forces in a multi-year strategic partnership to fast-track the development and manufacturing of specialized active pharmaceutical ingredients (APIs) for rare diseases and niche therapies. This collaboration leverages HRV's global market access and Haleos' manufacturing expertise to introduce 5-7 new high-value molecules annually, targeting underserved patient populations worldwide....
|
|
|
|
|
|
|
19.01.26 - 18:18
|
Yidu Tech Founder Gong Yingying on Scaling AI for Global Healthcare (Bloomberg)
|
|
|
Yidu Tech founder and Chairlady Gong Yingying says China's supportive regulatory environment and massive market size are accelerating the development of artificial intelligence in the healthcare industry. Speaking to Bloomberg TV's Haslinda Amin in Davos, she said AI could work with doctors to provide better healthcare for patients. (Source: Bloomberg)...
|
|
|
19.01.26 - 17:00
|
Biotech firm poised to transform mRNA medicine with game-defining drug delivery technology (SCMP)
|
|
|
[The content of this article has been produced by our advertising partner.]
Since their emergency-use rollout in late 2020, billions of doses of COVID 19 vaccines built on disruptive mRNA technology have been administered worldwide, saving hundreds of millions of lives. Now, the global pharmaceutical industry is pushing far beyond next generation vaccines. Companies worldwide are rapidly expanding into mRNA based therapeutics aimed at chronic and autoimmune diseases, rare genetic disorders,......
|
|
|
|
|
|
|
|
|
|
|
18.01.26 - 11:21
|
Krankenkassen: Reform muss bei den Ausgaben ansetzen (DPA-AFX)
|
|
|
BERLIN (dpa-AFX) - Die gesetzlichen Krankenkassen haben vor Reformen im Gesundheitswesen zulasten der Versicherten gewarnt. Der Chef des Spitzenverbands der Krankenkassen, Oliver Blatt, sagte den Zeitungen der Funke-Mediengruppe zu Vorschlägen wie einer ......
|
|